{"paper_id":"5ba0b2e7-a80f-4b59-a3d1-7519fcf44b9d","body_text":"Page 1/22\nUterine-derived exosomes induce the M2 polarization ofmacrophages via miR210-3p to promote the development ofendometriosis\nShengnan Chen \nThe Second Xiangya Hospital of Central South University\nYing Jiang \nThe Second Xiangya Hospital of Central South University\nXiaoshan Chai \nThe Second Xiangya Hospital of Central South University\nZhaoying Chen \nThe Second Xiangya Hospital of Central South University\nHao Tian \nThe Second Xiangya Hospital of Central South University\nMin Liu \nThe Second Xiangya Hospital of Central South University\nTianyu Zhu \nThe Second Xiangya Hospital of Central South University\nWanwan ShangGuan \nThe Second Xiangya Hospital of Central South University\nXianqing Wu  (  xianqing0302@csu.edu.cn )\nThe Second Xiangya Hospital of Central South University\nResearch Article\nKeywords: Endometriosis, exosome, macrophage, miR-210-3p, ATP5D\nPosted Date: June 9th, 2023\nDOI: https://doi.org/10.21203/rs.3.rs-3030329/v1\nLicense:   This work is licensed under a Creative Commons Attribution 4.0 International License.   Read Full License\n\nPage 2/22\nAbstract\nBackground\nEndometriosis development is associated with peritoneal immune microenvironment abnormality. However, the specic\nmechanism is uncertain. Investigating peritoneal immune microenvironment regulation mechanisms could introduce novel\ntherapeutic strategies for effective endometriosis treatment.\nMethods\nWound healing assay, Transwell, colony formation were carried out to assess cells invasion and proliferation. Western blotting\nanalysis and ELISA were used to evaluate cells resistance to progesterone. Endometriosis C57BL6 mouse model was\nconducted to assess the impact of peritoneal inammatory environment and macrophage miR-210-3p on ectopic lesion\nimplantation and growth. miRNA and proteomics sequencing were carried out to verify the potential mechanisms inuencing\nthe development of endometriosis.\nResults\nMedium conditioned of peritoneal macrophages from patients with endometriosis, as well as the medium conditioned of\nmacrophages treated with uterine-derived exosomes of endometriosis patients, promoted the proliferation, invasion and\nprogesterone resistance of cells. Interestingly, Uterine-derived exosomes of endometriosis patients increased miR-210-3p\nexpression in peritoneal macrophages. In vivo experiments conrmed that macrophages lentivirally transduced with miR-210-\n3p inhibitor can signicantly decrease the number and volume of endometriotic lesions. Mechanistically, miR-210-3p\nsignicantly induced M2 macrophage polarization by inhibiting the expression of ATP5D, and promoted cells migration.\nConclusions\nUterine-derived exosomes of endometriosis patients upregulated the expression of miR-210-3p in peritoneal macrophages to\ninhibit ATP5D, driving macrophages polarization towards M2 and promoting the development of endometriosis.\nBackground\nEndometriosis is a common, oestrogen-dependent, chronic gynaecological disorder associated with pelvic pain and infertility,\naffecting about 10% of reproductive-aged women[1]. The development of endometriosis involves hormonal imbalances,\nimmunological, proinammatory, and proangiogenic processes[2]. As a result, the precise pathogenic mechanisms of\nendometriosis are not well-identied.\nAt present, the widely accepted theory is Sampson's theory of retrograde menstruation[3]. It is not known why only 6–10% of\nwomen develop endometriosis despite retrograde menstruation occurring in 76–90% of women[4]. An attractive hypothesis is\nthat the endometrial stromal cells (hESCs) containing stem cell characteristics or endometrium-derived mesenchymal stem\ncells (EMSCs)[5–7] may be abnormally shed through the fallopian tube into the peritoneal cavity in affected women, leading to\nthe formation of ectopic implants in endometriosis. There are reports indicating that reuxed ectopic stromal stem cells display\ndiverse features from eutopic stromal stem cells attributable to local microenvironment differences in the abdominal cavity [8,\n9]. Consequently, some scholars have proposed that the development of endometriosis may involve the interaction between\nMSCs and peritoneal immune cells.\nAlthough the pathogenesis of endometriosis remains elusive, growing evidence has demonstrated that it may be related to an\naberrant immune response[10, 11]. Peritoneal macrophages play a key role in the establishment and maintenance of\nendometriosis by regulating the immune and peritoneal environments[12, 13]. In endometriosis, abnormal levels of cytokines,\n\nPage 3/22\ninterferon, and macrophage colony-stimulating factor in peritoneal uid lead to functional scavenger receptor deciency in\nperitoneal macrophages[14, 15]. This decrease in phagocytic activity may contribute to the growth of ectopic endometrial cells.\nAdditionally, based on their activation state and function, macrophages can be classied into 'classically activated' M1 and\n'alternatively activated' M2. Bacci et al.[16] conrmed that patients with endometriosis mainly have peritoneal uid containing\nM2-polarized macrophages. Moreover, the focus of endometriosis has a higher concentration of M2 macrophages than\nsurrounding tissues. Injection of M2-polarized macrophages into the peritoneal cavity of mice promotes the formation of large\nectopic lesions, while M1-polarized macrophages only produce small lesions, indicating that M2-polarized macrophages can\nfacilitate growth of ectopic lesions[17]. Our previous research found that[18] eutopic endometrial cells can alter the immune\nphenotype of peritoneal macrophages. However, the mechanism by which eutopic endometrial cells regulate the peritoneal\nimmune microenvironment from a distance is unclear as they are located in the uterine cavity.\nExosomes[19] are a circular monolayer structure with a diameter of 40 ~ 100nm, which can carry a variety of proteins, mRNAs,\nand miRNA. It is a carrier of natural intercellular information, which can remotely regulate the function of receptor cells and\nparticipate in the processes of immunity, antigen presentation, cell migration, angiogenesis, and cell growth[20]. The effect of\nexosomes on macrophage polarization has been conrmed in various disease states. Zhao et al.[21] demonstrated that\nmesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia -reperfusion injury via modication of the\npolarization of M1 macrophages to M2 macrophages. Xin et al.[22] constructed a scaffold with mesenchymal stem cell-derived\nexosomes to promote endometrium regeneration and fertility restoration through macrophage immune regulation. Sun et al.\n[23] found that exosomes from endometrial stromal cells of endometriosis patients could induce macrophages into M2\nphenotype, decreasing their phagocytic ability.\nStudies have shown that endometrial exosomes released into the uterine cavity can reux into the peritoneal cavity and\ncommunicate with other cells to inuence the implantation of ectopic endometrial lesions[24, 25]. Our hypothesis is that\nuterine-derived exosomes can modulate peritoneal macrophages to create an appropriate environment for the attachment of\nectopic endometrial lesions. In this study, we investigated the specic mechanisms by which uterine-derived exosomes regulate\nperitoneal macrophages to promote the development of endometriosis.\nMethods\nClinical specimens\nPatients who underwent laparoscopic surgery for ovarian endometriosis were enrolled in the EMs group (n = 30). Patients who\nunderwent surgical treatment for other benign gynecological diseases, such as simple ovarian cysts, uterine incision diverticula,\nor tubal ligation were enrolled in the control group (n = 30). Samples of peritoneal uid, uterine uid, and normal endometrial\ntissues were collected from all patients. All of the samples were collected at the time of surgery at the Second Xiangya Hospital\nof Central South University. Informed consent was obtained from each patient, and the study was approved by the Medical\nEthics Committee of the Second Xiangya Hospital of Central South University (#2020-065). Endometrial tissue and peritoneal\nuid were treated within 6 hours of collection, while the uterine uid was stored in a freezer at -80 ℃  after centrifugation. All of\nthe patients had normal ovulation with regular menstrual cycles, and none of the patients had received steroid hormonal\nmedications for at least 3 months.\nIsolation of primary cells and cell culture\nNormal endometrial tissues were minced and digested in F12/DMEM containing collagenase I(2.5mg/ml) and\ndeoxyribonuclease I(0.1mg/ml) at 37°C for 40 minutes. The dispersed cells were separated by ltration through a 40µm cell\nstrainer. The cells were plated onto 25cm2 Falcon tissue culture asks and maintained in F12/DMEM supplemented with 10%\nfetal bovine serum (FBS) at 37°C in a humidied atmosphere containing 5% CO2. Endometrial stromal cells (hESCs) were\npuried by adherent culture, and the cells were used between passages for 3–6.\n\nPage 4/22\nThe peritoneal uid was collected, centrifuged, and recuperated with PBS. Then, it was layered on the same volume of Ficoll\nand centrifuged for 20 minutes at 2000rpm and at room temperature. The cloud-like layer was collected and washed twice with\nPBS before inoculating the cells in a 6-well plate, with a density of 1 × 106/well. They were cultured in RPMI1640 medium\ncontaining 10% FBS for 2 hours to remove non-adherent cells. Only the remaining adherent cells were considered peritoneal\nuid macrophages. After culturing for 24h-48h, the supernatant and RNA were collected.\nThp1 and RAW264.7 cells were purchased from National Collection of Authenticated Cell Cultures. These cells were cultured in\nRPMI1640 or DMEM High-Glucose medium supplemented with 10% FBS and 1% penicillin/streptomycin.\nSurface marker prole and differentiation capacity\nThe characteristics of the stem cells[7] were identied by ow cytometry. After 3 generations of culture, the hESCs cells were\nincubated with labeled surface antibodies: PerCP-CyTM5.5 Mouse Anti-Human CD45, APC Mouse Anti-Human CD146, PE\nMouse Anti-Human CD140b on ice for 30 minutes. Then, the cells were resuspended in PBS for FCM analysis.\nhESCs were inoculated in a 6-well plate and cultured in DEME/F12 medium for 24 hours until reaching 70% conuence. Then,\nan osteogenic differentiation medium was used to induce osteogenesis. The culture medium was changed every 7 days, and\nalizarin red staining solution was used to detect calcium deposition on the 28th day. Then, an osteogenic differentiation\nmedium was used to induce osteogenesis. The culture medium was changed every 7 days, and alizarin red staining solution\nwas used to detect calcium deposition on the 28th day.\nWound healing assay\nThe third generation of hESCs in the logarithmic growth phase were seeded into a 6-well plate with a density of 5 × 105\ncells/well. When the cell density reached 80 to 90%, a scratch was made in the monolayer using a 100µl pipette tip in the\nmiddle of each well. Wound healing within the same scratched line was then observed and photographed at specic time\npoints (0 h, 24 h, or 48 h). Each experiment was performed three times.\nTranswell\n5 × 104 cells were seeded into the upper Transwell chamber using an 8µm pore size lter membrane and culture medium\nsupplemented with 10% FBS. Macrophage conditioned medium was added to the lower chamber at a ratio of 1:1 as a\nchemoattractant. The cells that had migrated to the lower surface of the lter were xed in a 4% paraformaldehyde and stained\nwith crystal violet for 30 minutes. The natural air-dried lter membrane was used to count the migrated cells. Three\nindependent experiments were conducted.\nColony Formation Assay\nThe third generation hESCs were digested and seeded directly in 6-well plates (3× 103 cells/well) for the colony formation\nassay and cultured in the presence of 10% FBS at 37°C with 5% CO2. Two weeks later, the cells were xed with 4%\nparaformaldehyde and stained with crystal violet for 30 minutes. Count the number of colonies with diameter > 0.5mm.\nIsolation of exosomes from uterine uid\nThe uterine uid collected during the operation was thawed at room temperature and centrifuged at 3000 × g for 20min to\nremove cells. Then, the supernatant is passed through a 0.22µm lter to remove cellular debris. The exosomes were extracted\nby Exosome Purication kit-exoupur (ECHO BIOTECH, Beijing, China), then concentrated by ultralter tube at 30000 rpm for\n30min. The isolated exosomes were characterized by transmission electron microscopy, nanoparticle tracking analysis (NTA)\nand western blot.\nTreatment of macrophages with uterine uid-derived exosomes\nUterine uid-derived exosomes were labeled using a PKH67 Fluorescent Cell Linker Kit (Sigma-Aldrich, Saint Louis, MO, USA) to\ndetect the direct transfer of the exosomes into macrophages (Thp1). The puried exosomes were resuspended in PBS and\n\nPage 5/22\nlabeled with PKH67. PBS without exosomes was used as control. The internalization of exosomes was conducted by\nincubating Thp1 cells at 37°C with a nal concentration of 100µg/ml. Fluorescent signals were detected after 48h.\nCell transfection\nThe miR-210-3p mimics, inhibitor and respective negative controls (scrambled oligos) were obtained from RiboBio. According\nto the manufacturer's instructions, transfections were performed using Lipofectamine 3000.\nTransfection of RAW264.7 with miR-210-3p by lentiviral vector\nmiR-210-3p short hairpin RNA lentivirus (miR-210-3p inhibitor) and corresponding negative control lentiviruses (miRNA-NC)\nwere purchased from Genechem Co. Ltd (Shanghai, China). Cells were infected with lentiviruses at 100 MOI (multiplicity of\ninfection) for 6h and replaced with fresh medium for another 48h. The green uorescent protein signal was detected by a\nuorescence microscope and gene transfection eciency was veried by PCR.\nEstablishment of the endometriosis mouse model.\nSix-week-old female nonpregnant C57BL6 (20g) were obtained from the Laboratory Animal Research Center of the Second\nXiangya Hospital of Central South University. All animal handling and experimental procedures were approved by the Animal\nExperimental Ethics Committee of the Second Xiangya Hospital of Central South University (#20220059).\nDonor mice were initially treated with estradiol benzoate (3µg/mouse) and sacriced after 7 days. The uterus was removed and\nimmediately placed in saline solution. The two uterine horns were excised and split longitudinally with a surgical blade, and the\nendometrium was carefully separated from muscles. Each endometrium was identically processed and disrupted into\nsegments smaller than 1 mm. On the 0th day of modeling, the fragment was injected into the abdominal cavity of recipient\nmice. Overall, segments of endometrium from one uterus were placed in 400µl PBS and injected into two recipient mice. The\nmice were sacriced by cervical dislocation 28 days after endometrial tissue injection, measure and record the size and volume\nof the lesions. In the experimental group, mice received intraperitoneal injections of 2mg/kg LPS, every 3 days. (control group,\ninjection of PBS).\nFCM analysis\nAfter euthanizing the animals, peritoneal cells were retrieved by peritoneal lavage with 7ml of ice-cold washing buffer PBS.\nAfter shaking the mice, peritoneal cells were collected. CD16/32 was used to block Fc receptors, F4/80 and CD11b were used\nas pan-macrophage markers, iNOS and CD206 were used to detect M1 and M2 macrophages. The peritoneal macrophages\nwere incubated with antibodies. After washing with PBS, the cells were resuspended in PBS for FCM analysis.\nRNA extraction and quantitative real-time PCR\nTotal RNA was extracted using TRIzol reagent. RNA was reverse-transcribed into cDNA using the HiScript II Q RT SuperMix for\nqPCR (+ gDNA wiper) (No. R223-01;Vazyme), followed by qRT-PCR using ChamQ Universal SYBR qPCR Master Mix (No. Q711-\n02; Vazyme) under the following thermal cycling conditions: initial denaturation at 95°C for 30 s, followed by 40 cycles of 95°C\nfor 5 s and 60°C for 30 s, and lastly 95°C for 15 s, 60°C for 1 min, and 95°C for 15 s. All PCR primers were designed and\nsynthesized by Sangon Biotech (Shanghai, China; Supplemental table S1). The threshold cycle method (2 −  ΔΔ CT) was used to\ncalculate the relative expression levels normalized to GAPDH levels.\nWestern blot analysis\nThe total protein was extracted, and the protein concentration was determined by BCA. The proteins separated via SDS-PAGE\nand transferred to PVDF membranes, and then blocked in 5% non-fat milk at room temperature for 2h. The membranes were\nincubated overnight at 4°C with primary antibodies. According to the manufacturer's instructions, HRP conjugated secondary\nantibodies and ECL kits were used to detect immunoreactive protein.\nTMT Proteomics\n\nPage 6/22\nTotal proteins of Thp1 transfected with miR-210-3p were extracted and their concentrations were quantied by the BCA assay\n(Thermo Fisher Scientic, Waltham, MA). Peptides were labeled with TMT according to the manufacturer's protocol. For each\nsample, 2ug of total peptides were separated and analyzed with a nano UPLC(EASY nLC1200) coupled to a Q Exactive HFX\nOrbitrap instrument (Thermo Fisher Scientic) with a nano electrospray ion source. Data dependent acquisition (DDA) was\nperformed in prole and positive mode with Orbitrap analyzer.\nStatistical analysis\nThe data are presented as the mean ± SD from at least three independent experiments. Statistical signicance was measured\nusing Student’s t test (two-tailed). A value of p < 0.05 indicates that the difference was statistically. All statistical analyses were\nperformed with GraphPad Prism 8.0.\nResults\nAbdominal inammatory microenvironment promotes the developmentof endometriosis\nEstablishment of a mouse endometriosis model, and simulation of different abdominal environments by injecting LPS and\nPBS into the peritoneal cavity. Typical endometriosis-like lesions were formed in the mesentery or peritoneum 28 days after\nimplantation (Fig. 1a, b). The results showed that the volume of lesions in LPS group was signicantly larger than that in PBS\ngroup, and the number of lesions showed the same trend (Fig. 1c). We conducted immunocytochemical staining for Ki-67\n(proliferation marker) and vimentin (mesenchymal marker) followed by uorescence microscopy, and then observed that\nabdominal inammation signicantly promoted the proliferation of endometrial stromal cells (Fig. 1d). At the same time, the\nperitoneal uid of mice was collected for FCM analysis, it was found that the number of macrophages in LPS group was more\nthan that in PBS group, and M2 macrophages were dominant in both groups (Fig. 1e, f).\nPeritoneal macrophages promote the proliferation and migration ofhESCs\nPrimary isolated hESCs expressed high levels of mesenchymal stem cell surface markers CD140b and CD146, and have the\npotential for osteogenic and adipogenic differentiation (Supplemental Fig. 1a, b, c).\nPeritoneal uid macrophages conditioned medium from patients with endometriosis (EMs) and patients without endometriosis\n(Control) was used to interfere with hESCs. As shown in Fig. 2a, b, the results of wound healing assays and transwell migration\nwere performed to assess the inuence of macrophages on the migration of hESCs. As expected, macrophages from EMs\nremarkably enhanced the migration capacity of hESCs. In addition, Western blot analysis (Fig. 2c, d) showed that compared to\nthe Control group, macrophages from EMs enhanced the expression of MMP9, MMP2 and N-Cadherin in hESCs. Subsequently,\nFCM analysis and colony formation revealed that macrophages from EMs promoted the proliferative capacity of hESCs\n(Fig. 2e, f).\nTo assess the inuence of macrophages on progesterone resistance of hESCs, we induced decidualization in vitro. Then we\nexamined the expression of estrogen (ER) and progesterone receptors (PR) in hESCs (Fig. 2g). Western blot analysis revealed\nthat peritoneal macrophages in patients with endometriosis reduced the expression of PR and epithelial marker E-cadherin and\nenhanced the expression of mesenchymal marker N-Cadherin, which means that the differentiation ability of hESCs into\nepithelial cells and decidualization was impaired. Consistent with the ndings, ELISA result showed (Fig. 2h) macrophages\nfrom EMs decreased the expression of the decidualization markers IGFBP-1 in hESCs.\nThe effect of macrophages treated with exosomes on hESCs\nEMs-exosomes (EMs-exo) from uterine uid of patients with endometriosis and Control-exosomes (Control-exo) from uterine\nuid of patients without endometriosis showed similar characteristics of 100nm diameter, biconcave morphological features\n\nPage 7/22\n(Fig. 4a, b), and positive staining for exosomal makers TSG101, HSP70 and CD63(Fig. 4c). To elucidate the role of exosomes in\nthe macrophages, we used the Thp1 cell line as model of macrophages in vitro. The exosomes were labeled with PKH67 and\nincubated with the macrophages. Uterine uid-derived exosomes with green uorescence were observed in the macrophages\n(Fig. 4d). The results show that we successfully extracted uterine-derived exosomes and that macrophages can phagocytose\nuterine-derived exosomes.\nTo investigate the function of macrophages treated with uterine-derived exosomes in hESCs. Thp1 were incubated with EMs-\nexo and Control-exo for 48 hours, conditioned medium was collected and co-cultured with hESCs. Wound healing assays and\ntranswell assays revealed that EMs-exo group enhanced the migration of hESCs (Fig. 3a, b). Similarly, western blot analysis\nshowed that EMs-exo group increased the protein level of MMP9, MMP2 and N-Cadherin in hESCs (Fig. 3c, d). Moreover, FCM\nanalysis and colony formation indicated that compared to the Control-exo group, EMs-exo group promoted the proliferative\ncapacity of hESCs (Fig. 3e, f).\nFurthermore, co-culturing EMs-exo conditioned medium with hESCs resulted in a downregulation of PR and E-cadherin\nexpression and an upregulation of N-cadherin in hESCs (Fig. 3g). Similarly, ELISA results showed that the secretion of IGFBP1\nin hESCs was signicantly decreased in the EMs-exo group compared to the control group (Fig. 3h). These results suggested\nthat macrophages co-incubated with EMs-exo can promote the proliferation and migration of hESCs, resulting in progesterone\nresistance and impairs decidualization.\nmiR-210-3p is overexpressed in macrophages treated with EMs-exo\nTo assess endometriosis-induced changes in the expression of exosomal miRNAs, we conducted sequencing of small RNAs\nfrom endometriosis and non-endometriosis uterine-derived exosomes and eutopic endometrium, 9 differentially expressed\nmiRNAs were identied in exosomes, while 22 differentially expressed miRNAs were identied in endometrium. The miRanda\nand TargetScan databases were used to predict the target genes of the differentially expressed miRNAs. Functional enrichment\nanalysis showed that the target genes of exosomal miRNA were mainly involved in the positive regulation of macrophage\ndifferentiation, cytokine activity, ATP binding and glycogen metabolic process (Supplemental Fig. 2a, b). miR-210-3p expression\nwas signicantly upregulated in uterine-derived exosomes and eutopic endometrium from patients with endometriosis (Fig. 4e,\nf), and qRT-PCR results also conrmed that it was markedly elevated in EMs-exo and eutopic endometrium[26]. Therefore, we\nselected this miRNA for further analyses. Notably, as shown in Fig. 4g, miR-210-3p levels were signicantly higher in peritoneal\nuid macrophages from endometriosis, compared with control group. Similarly, qRT-PCR results also conrmed that miR-210-\n3p expression of Thp1 was obviously upregulated after EMs-exo treatment for 48h (Fig. 4h).\nBased on the above results, we speculated that the uterine-derived exosomes of patients with endometriosis may promote the\ndevelopment of endometriosis by upregulating the expression of miR210-3p in macrophages.\nmiR-210-3p promotes the proliferation and migration of hESCs in vitro\nTo clarify the effect of miR-210-3p on endometriosis, we rst silenced miR-210-3p by transfecting miR-210-3p inhibitor in Thp1.\nNext, transwell migration and wound healing assays were performed to assess whether silenced miR-210-3p could reverse the\neffect of peritoneal macrophages on the migration of hESCs. As shown in Fig. 5a, b, c, d, the low-expression of miR-210-3p\ninhibited the migration capacity in hESCs. Subsequently, the results of colony formation and FCM assays revealed that the low-\nexpression of miR-210-3p in macrophages inhibited the proliferative capacity of hESCs (Fig. 5e, f). Western blot analysis\nrevealed that downregulating miR-210-3p enhanced the expression of epithelial marker E-cadherin and reduced the expression\nof mesenchymal marker N-cadherin (Fig. 5g). The results showed that the ability of mesenchymal stem cells to differentiate\ninto epithelial cells was enhanced and the decidualization ability was improved after the inhibition of macrophage miR-210-3p,\nand the decidualization marker IGFBP1 showed the same trend (Fig. 5h). These results suggested that inhibiting the expression\nof miR-210-3p in macrophages can inhibit the migration and proliferation of hESCs, and improve the progesterone resistance\nof hESCs.\nmiR-210-3p promotes the development of endometriosis in vivo\n\nPage 8/22\nMacrophage-depleting liposomes containing clodronate were used to deplete mouse peritoneal macrophages, then the miR-\n210-3p of the mouse macrophage cell line RAW264.7 was knocked out using a lentivirus and intraperitoneally injected (Fig. 6a).\nAt sacrice, 28 days after intraperitoneal injection of syngeneic endometrial tissue, lesions had developed in all mice (Fig. 6b,\nc). Endometriotic lesions with low-expression of miR-210-3p in mouse macrophages were signicantly bigger, which was\nreected by their total volume and number (Fig. 6d). Immunouorescent staining of Ki-67 and vimentin were performed that\ndownregulation of miR-210-3p in macrophages inhibited the proliferation capacity of endometrial stromal cells (Fig. 6e). These\nresults implied that inhibiting miR-210-3p in macrophages effectively protected mice from endometriosis, and show that miR-\n210-3p may be a valuable biomarker for non-invasive diagnosis and treatment of endometriosis.\nmiR-210-3p induces M2 macrophage polarization by ATP5D\nTo identify the molecular mechanism of miR-210-3p in macrophages, we transfected miR-210-3p mimics and inhibitors, and\nthen conducted proteomic sequencing. According to the results, we identied a total of 360 differentially expressed proteins\nbetween miR-210-3p overexpression and the control group, and 37 differentially expressed proteins between miR-210-3p\nunderexpression and the control group.(Fig. 7a, b). Subsequently, functional analysis of the differential proteins was\nperformed. It was found that inhibition of miR-210-3p mainly affected ATP metabolic pathways, such as oxidative\nphosphorylation pathway, ATP metabolism and ATP synthase activity (Supplemental Fig. 3b, d). KEGG showed that miR-210-\n3p overexpression mainly affected immunoinammatory pathways (Supplemental Fig. 3a, c), such as IL-17 signaling pathway,\nTNF signaling pathway and Nod-like receptor signaling pathway. We screened out differential proteins with consistent\nexpression trends in the two groups (Fig. 7c), and found that the expression of ATP5F1D, FAU and MST1L was inhibited in\nmacrophages when miR-210-3p was overexpressed, while the three proteins were up-regulated in macrophages when miR-210-\n3p was underexpressed.\nThe qRT-PCR and WB results conrmed that ATP5F1D (ATP5D) expression was consistent with the proteomic results (Fig. 7d,\ne). The expression of ATP5D was signicantly reduced in abdominal macrophages of patients with endometriosis as\ncompared to non-endometriosis patients (Fig. 7f). Therefore, we hypothesize that the excessive expression of miR-210-3p in\nmacrophages inhibits the expression of ATP5D, affecting the function of macrophages.\nBy knocking down ATP5D expression in macrophages, the expressions of CD206, CD163 and IL10 in macrophages were\nsignicantly increased, while the expressions of iNOS and CCR7 were signicantly decreased (Fig. 7g), suggesting that\ninhibiting ATP5D expression drive the M2 polarization of macrophages. Subsequently, the supernatant of macrophages with\nlow-expression of ATP5D was co-cultured with hESCs for 48 hours, wound healing assays and transwell indicated that\nmacrophages with decreased expression of ATP5D remarkably enhanced the migration capacity of hESCs (Fig. 7h, i).\nDiscussion\nEndometriosis is a common benign gynecological disease; however, its biological behavior regarding distant metastasis and\ninvasion is similar to that of malignant tumors[27]. The pathogenesis of endometriosis is still unclear[1, 2, 10], despite a large\nbody of evidence suggests that, in addition to hormonal and intrinsic abnormalities of the endometrium, the immune system\nplays a key role in its development[28, 29].\nImmune dysfunction is believed to play a role in both the initiation and progression of endometriosis by creating a\nmicroenvironment that encourages the ectopic survival and implantation of endometrial cells[30, 31]. Our study has\ndemonstrated that the inammatory abdominal microenvironment is conducive to the implantation and growth of ectopic\nendometrial cells, and that peritoneal macrophages are primarily M2 macrophages. Furthermore, we found that peritoneal\nmacrophages from endometriosis patients can stimulate the migration, invasion, and proliferation of hESCs while also\ninducing their progesterone resistance. This evidence suggests that the changes of macrophages establish an \"immune\ntolerance\" microenvironment locally in the abdominal cavity, providing a suitable \"soil\" for the implantation and growth of\nectopic lesions[32–34]. Consequently, there is a new research focus on regulating the abdominal immune microenvironment,\n\nPage 9/22\nreprogramming macrophage epigenetic, and disrupting the \"peaceful coexistence\" between ectopic endometrial tissue and the\nlocal microenvironment.\nExosomes act as natural carriers of intercellular information and play a crucial role in immune regulation, particularly in remote\nregulation[19]. Our results demonstrate that uterine-derived exosomes from endometriosis patients, when administered to\nperitoneal macrophages, stimulate the proliferation and migration of hESCs while also inducing their resistance to\nprogesterone. Our earlier study revealed that miR-210-3p expression was upregulated in both uterine-derived exosomes and\neutopic endometrial tissue from women with endometriosis[26]. Our present study shows that miR-210-3p expression is\nupregulated in peritoneal macrophages from women with endometriosis. Therefore, we hypothesize that exosomes from the\nuterine cavity may cause the ectopic implantation and growth of endometrial cells by elevating miR-210-3p expression in\nperitoneal macrophages.\nIn the present study, we show that upregulation of macrophage miR-210-3p inhibits ATP5D expression, thereby enhancing the\ninvasion and migration of hESCs. Moreover, downregulating macrophage ATP5D expression induces M2 polarization, which\nmay be a mechanism by which uterine-derived exosomes promote endometriosis development. ATP5D is a subunit of\nmitochondrial ATP synthase that plays an important role in catalyzing the synthesis of ATP in the mitochondria[35]. Decreased\nmitochondrial ATP generation typically increases AMP concentration and shifts metabolism from synthetic to catabolic[36].\nThe metabolic state of macrophages not only reects the intrinsic stability of the local microenvironment but also affects the\nlocal microenvironment by altering their own function[37–40]. Therefore, exosomes derived from the uterine cavity may affect\nthe function of macrophages by disrupting their metabolism through the alteration of ATP synthase in peritoneal\nmacrophages.\nSimilar to the \"tumor niche\" hypothesis[41], the immune microenvironment of the abdomen (\"soil\") undergoes changes before\nendometrial cells (\"seeds\") reach the peritoneal cavity, promoting the escape of the \"seeds\" from immune surveillance and\naiding in their settlement and growth. Uterine-derived exosomes may function as a mode of information transfer. In fact,\nendometriotic exosomes may retrogradely enter the pelvic area and adjust local cell functions, shaping a suitable \"soil\" for\nectopic endometrial growth, which might be key molecules in the pathogenesis of endometriosis[42–44]. Our data suggest that\nuterine-derived exosomes inhibit macrophage ATP5D expression, driving macrophages towards M2 polarization, establishing a\nsuitable soil of local immune inhibition and promoting ectopic endometrial settlement. Additionally, study found that exosomes\ninduce macrophage polarization to create a favorable microenvironment for angiogenesis, regulating the development of\nendometriosis[45, 46].\nOur study demonstrates that uterine-derived exosomes can regulate the expression of miR-210-3p in peritoneal macrophages to\ninduce the formation of an immunosuppressive microenvironment. These ndings provide new insights into the role of uterine-\nderived exosomes in mediating the establishment of an immunosuppressive peritoneal microenvironment and show that miR-\n210-3p may be a valuable biomarker, and that inhibiting the expression of miR-210-3p in peritoneal macrophages may become\na novel immunotherapeutic strategy for endometriosis.\nHowever, our study has some limitations. Although the isolated extracellular vesicles from the uterus cavity may reect the\ninitial state of the cavity, it is hard to identify a specic source of exosomes. Because of species variation, we were unable to\ndirectly investigate the impacts of exosomes that are derived from the uterus of endometriosis patients on the implantation\nand growth of ectopic lesions and peritoneal macrophages in a mouse model. It is crucial to investigate the particular\nregulatory mechanism of uterine-derived exosomes on the function of macrophages, to gain a more profound understanding of\nthe role they plays in the growth and metastasis of hESCs.\nConclusion\nIn summary, we presented evidence of the mediation of growth and migration of hESCs by exosomes derived from the uterine\ncavity in endometriosis patients. We discovered that uterine-derived exosomes upregulate the expression of miR-210-3p in\n\nPage 10/22\nperitoneal macrophages to inhibit ATP5D, thereby promoting M2 polarization and reshaping the peritoneal immune\nmicroenvironment, which leads to the development of endometriosis.\nAbbreviations\nEMs\nEndometriosis\nhESCs\nHuman Endometrial Stromal Cells\nEMSCs\nEndometrium-derived Mesenchymal Stem Cells\nATP5D\nATP synthase, H + transporting, mitochondrial F1 complex, δ  subunit\nPBS\nPhosphate buffer saline\nLPS\nLipopolysaccharide\nPMA\nPhorbol-12-myristate-13-acetate\nWB\nWestern blot analysis\nPR\nProgesterone Receptor\nER\nEstrogen Receptor\nE-Ca\nEpithelial Cadherin\nN-Ca\nNeural Cadherin\nEMs-exo\nexosomes from uterine uid of patients with endometriosis\nControl-exo\nexosomes from uterine uid of patients without endometriosis\nNTA\nNanoparticle Tracking Analysis\nTEM\nTransmission Electron Microscope\nThp1\nHuman myeloid leukemia mononuclear cells\nMMP\nMatrix Metalloproteinase\nIGFBP1\nInsulin-like Growth Factor Binding Protein 1\nmimics NC\nMimics negative control\nInhibitor NC\nInhibitor negative control\nsiRNA\nSmall interfering RNA\n\nPage 11/22\nGO\nGene Ontology\nKEGG\nKyoto Encyclopedia of Genes\nDeclarations\nEthics approval and consent to participate\nThis study was approved by the Medical Ethics Committee of the Second Xiangya Hospital of Central South University\n(approval number:2020-065). Informed consent was obtained from each patient. All animal handling and experimental\nprocedures were approved by the Animal Experimental Ethics Committee of the Second Xiangya Hospital of Central South\nUniversity (approval number:20220059).\nConsent for publication\nNot applicable\nAvailability of data and materials\nAll data produced or analyzed in this study are contained in this published article and its supplementary information les. All\ndata used in the current study are available from the corresponding author on reasonable request.\nCompeting interests\nThe authors declare that they have no competing interests in this work.\nFunding\nThis study was supported by a grant from the National Natural Science Foundation of China (#81873826).\nAuthors' contributions\nSN.C and XQ.W conceived and designed the experiments; SN.C, Y.J and XQ.W prepared the manuscript; SN.C, Y.J and XS.C\nperformed the experiments; ZY.C, H.T, M.L, TY.Z, WW.SG collected the samples; SN.C and XQ.W analyzed the data. All authors\nread and approved the nal manuscript.\nAcknowledgements\nNone\nReferences\n1. Zondervan KT, Becker CM, Missmer SA. Endometriosis. Longo DL, editor. N Engl J Med [Internet]. 2020 [cited 2023 May\n31];382:1244–56. Available from: https://pubmed.ncbi.nlm.nih.gov/32212520/\n2. Giudice LC, Kao LC. Endometriosis. Lancet [Internet]. 2004 [cited 2023 May 31];364:1789–99. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/15541453/\n3. Halme J, HAMMOND M, … JH-O&, 1984 undened. Retrograde menstruation in healthy women and in patients with\nendometriosis. journals.lww.com [Internet]. [cited 2023 May 31]; Available from:\nhttps://journals.lww.com/greenjournal/Abstract/1984/08000/Retrograde_Menstruation_in_Healthy_Women_and_in.1.aspx\n4. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: ndings from the\nNational Health Interview Survey, 1984 to 1992. Am J Public Health [Internet]. 1996 [cited 2023 May 31];86:195–9.\nAvailable from: https://pubmed.ncbi.nlm.nih.gov/8633735/\n\nPage 12/22\n5. Zhang Z, Suo L, Chen Y, Zhu L, International GW-SC, 2019 undened. Endometriotic peritoneal uid promotes\nmyobroblast differentiation of endometrial mesenchymal stem cells. hindawi.com [Internet]. [cited 2023 May 31];\nAvailable from: https://www.hindawi.com/journals/sci/2019/6183796/\n. Khatun M, Sorjamaa A, Kangasniemi M, Sutinen M, Salo T, Liakka A, et al. Niche matters: The comparison between bone\nmarrow stem cells and endometrial stem cells and stromal broblasts reveal distinct migration and cytokine proles in\nresponse to inammatory stimulus. PLoS One [Internet]. 2017 [cited 2023 May 31];12. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/28419140/\n7. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the rst 10 years. Hum Reprod Update [Internet].\n2016 [cited 2023 May 31];22:137–63. Available from: https://pubmed.ncbi.nlm.nih.gov/26552890/\n. Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS, et al. Comparative study of human eutopic and ectopic\nendometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril\n[Internet]. 2011 [cited 2023 May 31];95. Available from: https://pubmed.ncbi.nlm.nih.gov/21047634/\n9. Nair ARKG, Pandit H, Warty N, Madan T. Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype. Int\nImmunol [Internet]. 2015 [cited 2023 May 31];27:195–204. Available from: https://pubmed.ncbi.nlm.nih.gov/25416515/\n10. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril [Internet]. 2012 [cited 2023 May\n31];98:511–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22819144/\n11. Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ [Internet]. 2014\n[cited 2023 May 31];21:216–25. Available from: https://pubmed.ncbi.nlm.nih.gov/24185619/\n12. Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum\nReprod Update [Internet]. 2019 [cited 2023 May 31];25:565–92. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/31424502/\n13. Ramírez-Pavez TN, Martínez-Esparza M, Ruiz-Alcaraz AJ, Marín-Sánchez P, Machado-Linde F, García-Peñarrubia P. The Role\nof Peritoneal Macrophages in Endometriosis. Int J Mol Sci [Internet]. 2021 [cited 2023 May 31];22. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/34639133/\n14. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. Macrophage expression in endometrium of women with\nand without endometriosis. Hum Reprod [Internet]. 2009 [cited 2023 May 31];24:325–32. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/19049988/\n15. Weinberg J, Haney A, Xu F, Ramakrishnan S. Peritoneal uid and plasma levels of human macrophage colony-stimulating\nfactor in relation to peritoneal uid macrophage content. 1991 [cited 2023 May 31]; Available from:\nhttps://ashpublications.org/blood/article-abstract/78/2/513/168804\n1. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, et al. Macrophages are alternatively activated in\npatients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J\nPathol [Internet]. 2009 [cited 2023 May 31];175:547–56. Available from: https://pubmed.ncbi.nlm.nih.gov/19574425/\n17. Jeljeli M, Riccio LGC, Chouzenoux S, Moresi F, Toullec L, Doridot L, et al. Macrophage Immune Memory Controls\nEndometriosis in Mice and Humans. Cell Rep [Internet]. 2020 [cited 2023 May 31];33. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/33147452/\n1. Xie Q, He H, Wu YH, Zou LJ, She XL, Xia XM, et al. Eutopic endometrium from patients with endometriosis modulates the\nexpression of CD36 and SIRP- α  in peritoneal macrophages. J Obstet Gynaecol Res [Internet]. 2019 [cited 2023 May\n31];45:1045–57. Available from: https://pubmed.ncbi.nlm.nih.gov/30843336/\n19. Kalluri R, LeBleu VS. The biology , function , and biomedical applications of exosomes. Science [Internet]. 2020 [cited 2023\nMay 31];367. Available from: https://pubmed.ncbi.nlm.nih.gov/32029601/\n20. Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol [Internet].\n2018 [cited 2023 May 31];35:69–79. Available from: https://pubmed.ncbi.nlm.nih.gov/29289420/\n21. Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial\nischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res [Internet]. 2019 [cited\n2023 May 31];115:1205–16. Available from: https://pubmed.ncbi.nlm.nih.gov/30753344/\n\nPage 13/22\n22. Xin L, Lin X, Zhou F, Li C, Wang X, Yu H, et al. A scaffold laden with mesenchymal stem cell-derived exosomes for\npromoting endometrium regeneration and fertility restoration through macrophage immunomodulation. Acta Biomater\n[Internet]. 2020 [cited 2023 May 31];113:252–66. Available from: https://pubmed.ncbi.nlm.nih.gov/32574858/\n23. Sun H, Li D, Yuan M, Li Q, Zhen Q, Li N, et al. Macrophages alternatively activated by endometriosis-exosomes contribute to\nthe development of lesions in mice. Mol Hum Reprod [Internet]. 2019 [cited 2023 May 31];25:5–16. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/30428082/\n24. Campoy I, Lanau L, Altadill T, Sequeiros T, Cabrera S, Cubo-Abert M, et al. Exosome-like vesicles in uterine aspirates: a\ncomparison of ultracentrifugation-based isolation protocols. J Transl Med [Internet]. 2016 [cited 2023 May 31];14.\nAvailable from: https://pubmed.ncbi.nlm.nih.gov/27317346/\n25. Harp D, Driss A, Mehrabi S, Chowdhury I, Xu W, Liu D, et al. Exosomes derived from endometriotic stromal cells have\nenhanced angiogenic effects in vitro. Cell Tissue Res [Internet]. 2016 [cited 2023 May 31];365:187–96. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/26841879/\n2. Jiang Y, Chai X, Chen S, Chen Z, Tian H, Liu M, et al. Exosomes from the Uterine Cavity Mediate Immune Dysregulation via\nInhibiting the JNK Signal Pathway in Endometriosis. Biomedicines [Internet]. 2022 [cited 2023 May 31];10. Available from:\n/pmc/articles/PMC9775046/\n27. Giudice LC, Kao LC. Endometriosis. Lancet [Internet]. 2004 [cited 2023 May 31];364:1789–99. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/15541453/\n2. Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, et al. The Immunopathophysiology of Endometriosis. Trends Mol\nMed [Internet]. 2018 [cited 2023 May 31];24:748–62. Available from: https://pubmed.ncbi.nlm.nih.gov/30054239/\n29. Agostinis C, Balduit A, Mangogna A, Zito G, Romano F, Ricci G, et al. Immunological Basis of the Endometriosis: The\nComplement System as a Potential Therapeutic Target. Front Immunol [Internet]. 2021 [cited 2023 May 31];11. Available\nfrom: https://pubmed.ncbi.nlm.nih.gov/33505394/\n30. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell [Internet]. 2021 [cited 2023\nMay 31];184:2807–24. Available from: https://pubmed.ncbi.nlm.nih.gov/34048704/\n31. Wang Y, Nicholes K, Shih IM. The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol [Internet]. 2020 [cited 2023\nMay 31];15:71–95. Available from: https://pubmed.ncbi.nlm.nih.gov/31479615/\n32. Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol [Internet]. 2013 [cited 2023\nMay 31];4. Available from: https://pubmed.ncbi.nlm.nih.gov/23372570/\n33. Wu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. J Neuroinammation [Internet]. 2017\n[cited 2023 May 31];14. Available from: https://pubmed.ncbi.nlm.nih.gov/28288663/\n34. Klemmt PA, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Curr Womens Health Rev [Internet].\n2018 [cited 2023 May 31];14:1–11. Available from: https://pubmed.ncbi.nlm.nih.gov/29861704/\n35. Oláhová M, Yoon WH, Thompson K, Jangam S, Fernandez L, Davidson JM, et al. Biallelic Mutations in ATP5F1D, which\nEncodes a Subunit of ATP Synthase, Cause a Metabolic Disorder. Am J Hum Genet [Internet]. 2018 [cited 2023 May\n31];102:494–504. Available from: https://pubmed.ncbi.nlm.nih.gov/29478781/\n3. Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity [Internet].\n2015 [cited 2023 May 31];42:406–17. Available from: https://pubmed.ncbi.nlm.nih.gov/25786173/\n37. He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, et al. Global characterization of macrophage polarization\nmechanisms and identication of M2-type polarization inhibitors. Cell Rep [Internet]. 2021 [cited 2023 May 31];37.\nAvailable from: https://pubmed.ncbi.nlm.nih.gov/34731634/\n3. Verdeguer F, Aouadi M. Macrophage heterogeneity and energy metabolism. Exp Cell Res. 2017;360:35–40.\n39. Yan J, Horng T. Lipid Metabolism in Regulation of Macrophage Functions. Trends Cell Biol [Internet]. 2020 [cited 2023 May\n31];30:979–89. Available from: https://pubmed.ncbi.nlm.nih.gov/33036870/\n40. Van den Bossche J, O’Neill LA, Menon D. Macrophage Immunometabolism: Where Are We (Going)? Trends Immunol\n[Internet]. 2017 [cited 2023 May 31];38:395–406. Available from: https://pubmed.ncbi.nlm.nih.gov/28396078/\n\nPage 14/22\n41. Liu Y, Cao X. Characteristics and Signicance of the Pre-metastatic Niche. Cancer Cell [Internet]. 2016 [cited 2023 May\n31];30:668–81. Available from: https://pubmed.ncbi.nlm.nih.gov/27846389/\n42. Horne AW, Saunders PTK. SnapShot: Endometriosis. Cell [Internet]. 2019 [cited 2023 May 31];179:1677-1677.e1. Available\nfrom: https://pubmed.ncbi.nlm.nih.gov/31951524/\n43. Sun H, Li D, Yuan M, Li Q, Li N, Wang G. Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome\npathway † . Biol Reprod [Internet]. 2019 [cited 2023 May 31];100:649–59. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/30295741/\n44. Qiu JJ, Lin XJ, Zheng TT, Tang XY, Zhang Y, Hua KQ. The Exosomal Long Noncoding RNA aHIF is Upregulated in Serum\nFrom Patients With Endometriosis and Promotes Angiogenesis in Endometriosis. Reprod Sci [Internet]. 2019 [cited 2023\nMay 31];26:1590–602. Available from: https://pubmed.ncbi.nlm.nih.gov/30808247/\n45. Sun H, Li D, Yuan M, Li Q, Zhen Q, Li N, et al. Macrophages alternatively activated by endometriosis-exosomes contribute to\nthe development of lesions in mice. Mol Hum Reprod [Internet]. 2019 [cited 2023 May 31];25:5–16. Available from:\nhttps://pubmed.ncbi.nlm.nih.gov/30428082/\n4. Li Y, Lyu P, Ze Y, Li P, Zeng X, Shi Y, et al. Exosomes derived from plasma: promising immunomodulatory agents for\npromoting angiogenesis to treat radiation-induced vascular dysfunction. PeerJ [Internet]. 2021 [cited 2023 May 31];9.\nAvailable from: https://pubmed.ncbi.nlm.nih.gov/33859878/\nFigures\n\nPage 15/22\nFigure 1\nAbdominal inammatory microenvironment promotes the development of endometriosis\n(a) Representative endometriosis-like lesions in the indicated treatment groups. (b)HE staining of ectopic endometrial tissues.\n(c)Total volume and number of lesions (n=7), the volume is the sum of the volumes of all lesions per mouse.\n(d)Immunouorescent staining of Ki-67 (red) and vimentin (green) in representative lesions. (e-f) Peritoneal macrophages were\nidentied by ow cytometry in the indicated treatment groups. Data are presented as mean ± SD. *P < 0.05, **P < 0.01, ***P <\n0.001, ****P < 0.0001. S = stroma, E = epithelium, G = gland.\n\nPage 16/22\nFigure 2\nPeritoneal macrophages promote the proliferation and migration of hESCs\n(a) Wound healing assay results showing the differences in migration capacities in hESCs(left), statistical analysis of the\nwound healing assay results (right). (b) Representative transwell results comparing the effects of macrophages on cell\nmigration between the Control and EMs groups(left), statistical analysis of the transwell assay results(right). (c, d) Protein\nexpression of MMP9, MMP2 and N-Cadherin in hESCs, treatment without E2 and P4, as determined by Western blotting.\nGAPDH was used as a loading control. (e) CD140b+CD146+ cell count by ow cytometry (left); statistical analysis of ow\nresults (right). (f) Representative images of the colony formation assay in the indicated cells (left); statistical analysis of the\ncolony formation results(right). (g)Western blotting analysis of the expression of PR, N-cadherin and E-cadherin in hESCs after\ninduced decidualization in vitro. (h)Expression of IGFBP1 in supernatant of hESCs after induced decidualization in vitro. *P <\n0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. EMs = endometriosis, Con = Control.\n\nPage 17/22\nFigure 3\nThe effect of macrophages treated with exosomes on hESCs\n(a, b, c, d) The invasion and migration of hESCs after treatment with macrophage-conditioned medium by wound healing assay\n(a), transwell (b) and protein expression of MMP9, MMP2 and N-Cadherin detected by Western blotting (c, d) in the indicated\ntreatment groups. (e, f) hESCs proliferative after treatment with macrophage-conditioned medium by ow cytometry(e) and\ncolony formation assay(f) in the indicated treatment groups.  g, h  hESCs progesterone resistance after treatment with\nmacrophage-conditioned medium by the levels of IGFBP1 detected by enzyme-linked immunosorbent assay kit (h), and protein\nexpression of PR , E-cadherin N-cadherin detected by Western blotting (g). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\n\nPage 18/22\nFigure 4\nmiR-210-3p is overexpressed in macrophages treated with EMs-exo\n(a)Transmission electron microscopy image of the morphology of exosomes in uterine uid (scale bar = 0.5 μ m).\n(b)Nanoparticle tracking analysis result on the size distribution of uterine uid-derived exosomes. (c)Western blot analysis of\nexosome positive markers CD63, HSP70 and TSG101. (d)Representative images of PKH67-labelled exosomes co-cultured with\nThp1. (e,f) The Volcano plot of the differentially expressed miRNAs in uterine-derived exosomes and eutopic endometrium from\nthe EMs compared with the control. (g) qRT-PCR assay of miR-210-3p expression in peritoneal uid macrophages of patients\nwith endometriosis (EMs, n=4) and patients without endometriosis (Control, n=4). (h) qRT-PCR assay of miR-210-3p expression\nin Thp1 co-cultured with EMs-exo and Control-exo. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\n\nPage 19/22\nFigure 5\nmiR-210-3p promotes the proliferation and migration of hESCs in vitro\n(a, b, c, d) Wound healing assay (a), Transwell (b) and expression of MMP9, MMP2 and N-Cadherin (c, d) comparing the effects\nof macophages on cell migration between the miR-inhibitor NC and miR-210-3p inhibitor groups. (e, f) Flow cytometry (e) and\ncolony formation assay(f) results showing the differences in proliferation capacities in the indicated group. (g, h) Effect of miR-\n210-3p expression in macrophages on decidualization of hESCs as determined by the expression of PR, E-cadherin and N-\ncadherin (g) and the levels of IGFBP1 (h).*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\n\nPage 20/22\nFigure 6\nmiR-210-3p promotes the proliferation and migration of hESCs in vivo\n(a) Schematic of experimental timeline and procedures. 24-48 hours before modeling, 150 μ l of liposomes were injected into the\nmouse peritoneal cavity to deplete the original macrophages, followed by a maintenance dose of 100 μ l biweekly. RAW264.7\ncells, 1 × 106 per transfer, were transferred every three days. (b, c) Representative images of ectopic endometriotic lesions in the\nindicated treatment groups (b) and the HE staining of ectopic endometrial tissues (c). (d)Total volume and number of lesions in\nthe indicated groups (n = 6). (e) Immunouorescent staining of Ki-67 (red) and vimentin (green) in representative lesions. *P <\n0.05.\n\nPage 21/22\nFigure 7\nmiR-210-3p induces M2 macrophage polarization by ATP5D\n(a, b) The Volcano plot of the differentially expressed proteins between the indicated group. (c) The Venn diagram shows\nproteins in the indicated groups with corresponding expression trends. (d) qRT-PCR analyses to verify the expression of\ndifferential proteins with corresponding expression trends. (e) Protein expression of ATP5D in the indicated cells as determined\nby Western blotting. (f) Western blot analysis of ATP5D in peritoneal macrophages from patients with endometriosis and non-\nendometriosis patients. (n=10). (g)qRT-PCR analysis of M1/M2 markers in the indicated infected cells. (h, i) hESCs invasion\nand migration after treatment with macrophage-conditioned medium by transwell (H) and wound healing assay (I) in the\nindicated treatment groups.*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\nSupplementary Files\nThis is a list of supplementary les associated with this preprint. Click to download.\n\nPage 22/22\nSupplementalFig1.tif\nSupplementalFig2.tif\nSupplementalFig3.tif\nSupplementaryMaterial..docx","source_license":"CC0","license_restricted":false}